+1.224.938.9523

HUMAN AMYLOID IMAGING CONFERENCE

January 17-19, 2018
Miami, Florida

HAI 2018 POSTER SESSIONS


Click the “+” to open each module; tables can be sorted by clicking on each item of the header row (board number, poster title, authors and presenter, respectively).  Additionally, each table is searchable (use the search field located at the top right of each module).

POSTER SESSION: 1 - Wednesday, January 17 - 2:00 - 3:30 pm
Board #Poster TitleAuthorsPresenter
13Explaining [18F]-AV-1451 variability in healthy controls across the lifespanBaker | Harrison | Maass | La Joie | JagustBaker, Suzanne
38A more accurate alternative to SUVR for quantifying binding rate-of-change in serial PETBecker | Price | JohnsonBecker, J. Alex
31Optimal time window for [18F]-AV-1451 binding quantification in AD using SUVrWimberley | Lagarde | Olivieri | Kuhnast | Caillé | Gervais | Sarazin | BottlaenderBottlaender, Michel
19Assessment of centiloid scaling values in test-retest evaluation using multiple image quantification software platformsBattle | Buckley | PillayBuckley, Christopher
9Novel alpha-synuclein positron emission tomography (PET) tracers for the diagnosis of Parkinson's diseaseCapotosti | Tsika | Molette | Ravache | Vokali | Rodriguez | Davranche | Darmency | Purohit | Paterson | Kroth | Stoehr | Lowe | Pfeifer | MuhsCapotosti, Francesca
37Preliminary report on the associations between CSF T-tau and P-tau with [18F]MK6240 bindingChamoun | Kang | Pascoal | Mathotaarachchi | Benedet | Shin | Therriault | Bouhachi | Hsiao | Massarweh | Chartrand | Soucy | Gauthier | Rosa-NetoChamoun, Mira
40Initial evaluation of correspondence between tau PET ligand [F-18]MK6240 and cognitive statusClark | Betthauser | Christian | Poetter | Sanson | Oh | JohnsonClark, Lindsay
6Comparison of parametric methods for visual assessment of [18F]Flutemetamol amyloid PET images in a cognitively healthy elderly populationCollij | Konijnenberg | Reimand | ten Kate | den Braber | Lopes Alves | Zwan | Yaqub | van Assema | Wink | Boomsma | Lammerstma | Scheltens | Visser | Barkhof | van BerckelCollij, Lyduine E.
30Simplified non-invasive tracer kinetic analysis for 18F-Florbetaben PET using a dual time-window acquisition protocolDe Santi | Barthel | Bullich | Koglin | Becker | Jovalekic | Stephens | SabriDe Santi, Susan
16Longitudinal tau quantitation with anatomically-guided PET image deblurringTabassum | Li | Becker | El Fakhri | Johnson | DuttaDutta, Joyita
14Centiloid validation of multi-atlas PET-SUVR analysis in the multi-tracer AMYPAD studyGrecchi | Foley | Wolz | Gispert | HillGrecchi, Elisabetta
20Optimized coffee-break protocol for quantitative [18F]flutemetamol studiesHeeman | Yaqub | Heurling | Lopes Alves | Gispert | Foley | Lammertsma | AMYPAD ConsortiumHeeman, Fiona
12A theoretical and empirical investigation of imperfect reference regionsHeurling | Smith | Strandberg | Ohlsson | Hansson | SchöllHeurling, Kerstin
4Optimal reference region analysis for [18F]MK6240 based on full kinetic modelingKang | Pascoal | Chamoun | Mathotaarachchi | Shin | Benedet | Therriault | Savard | Knight | Hsiao | Bouhachi | Massarweh | Chakravarty | Chartrand | bennacef | Ng | Soucy | Gauthier | Rosa-NetoKang, Min Su
23Methodologic considerations for calculating standard uptake value ratio amyloid reduction in the Gantenerumab open label extension studiesKlein | Delmar | Abi-Saab | Andjelkovic | Milosavljevic-Ristic | Seibyl | Marek | Martenyi | Baudler | Fontoura | DoodyKlein, Gregory
34Development of thiophene-based optical ligands that selectively detect tau pathology in Alzheimer’s diseaseShirani | Appelqvist | Bäck | Klingstedt | Cairns | Svensson | NilssonKlingstedt, Therése
41Low-dose NeuroPET scans for longitudinal PET: a feasibility study with FlortaucipirLois | Grogg | Schultz | Price | JohnsonLois, Cristina
27The impact of PET reconstruction method on measured amyloid SUVRMatthews | Andrews | SmithMatthews, Dawn
39Structure-binding relationship of quinoline derivatives on monoamine oxidase BOkamura | Harada | Furumoto | Arai | Yanai | KudoOkamura, Nobuyuki
25Prediction of cognitive decline by 18F-AV45 PET normalized to subcortical white matter reference regionOttoy | Niemantsverdriet | Verhaeghe | De Roeck | Struyfs | Somers | wyffels | Van den Bossche | Van Mossevelde | Ceyssens | Stroobants | Bjerke | Engelborghs | StaelensOttoy, Julie
36Voxel-wise determination of thresholds and accuracy of [18F]AV1451 and [18F]MK6240 ligands for neurofibrillary tanglesPascoal | Mathotaarachchi | Chamoun | Kang | Therriault | Struyfs | Ng | Savard | Shin | Knight | Benedet | Massarweh | Chakravarty | Soucy | Chartrand | Gauthier | Rosa-NetoPascoal, Tharick
32Amyloid tracer harmonization using a bootstrapped non-linear mappingProperzi | Buckkley | Mormino | Price | Sperling | Johnson | Schultz1Properzi, Michael
10Performance of supratentorial white matter reference regions for longitudinal quantification of [18F]flutemetamol PET scansSalvadó | Foley | Grecchi | Cardoso | Lopes-Alves | Markiewicz | Falcon | Battle | Lammertsma | Schmidt | Barkhof | Molinuevo | Gispert | AMYPAD ConsortiumSalvadó, Gemma
8Optimal centiloid transformations when using measurement methods differing in acquisition parameters and in quantification softwareSchwarz | Tosakulwong | Senjem | Gunter | Therneau | Vemuri | Lowe | JackSchwarz, Christopher
22Reduced acquisition time PET quantification applied to [18F]-florbetapirScott | Jiao | Melbourne | Markiewicz | Schott | Hutton | OurselinScott, Catherine J
15PET scanner variance in multi-center clinical trials using the Hoffman PhantomAdamczuk | Pannetier | Pham | Gorman | Runkle | Scott | SuhyScott, David
29Longitudinal change in brain perfusion in cognitively normal elderly subjects measured by early frames Florbetapir F 18 PETShcherbinin | Schwarz | Su | Charil | Hornbeck | Christensen | Eads | Benzinger | SimsShcherbinin, Sergey
7Validation of a new semi-quantitative Tau-PET analysis without image intensity normalizationShokouhi | Kang | GwirtsmanShokouhi, Sepi
24A non-invasive optical retinal imaging method to predict cerebral amyloid PET statusSoucy | Chevrefils | Sylvestre | Arbour | Rhéaume | Beaulieu | Rosa-Neto | Mathotaarachchi | Nasreddine | Gauthier | LesageSoucy, Jean-Paul
26Centiliod analysis in cross-sectional and longitudinal PiB PET studiesSu | Flores | Hornbeck | Speidel | Vlassenko | Gordon | Koeppe | Mintun | Klunk | Xiong | Morris | BenzingerSu, Yi
21Characterization of [3H]SIL26 binding to alpha-synuclein fibrilsSvensson | Paslawski | Svenningsson | Sohn | Strom | SandellSvensson, Samuel
33In vivo assessment of several 18F SV2A PET tracersCarroll | Alagille | Tress | Mistico | Constantinescu | Sandiego | Papin | Gouasmat | Zheng | Marek | Seibyl | Barret | TamagnanTamagnan, Gilles D.
17Tau and alpha synuclein selective binding compounds derived from Aprinoia Therapeutic’s PM-PBB3 binding-site focused compound collectionTempest | Jang | Tai | Higuchi | Ono | Shimada | Suhara | Zhang | Tamagnan | Carroll | Marek | Seibyl | Alagille | BarretTempest, Paul
3Regional distribution, asymmetry, and clinical correlates of tau uptake on [18f]av-1451 PET in atypical Alzheimer's DiseaseTetzloff | Graff-Radford | Tosakulwong | Martin | Machulda | Duffy | Clark | Senjem | Spychalla | Drubach | Jack Jr. | Lowe | Josephs | WhitwellTetzloff, Katerina
35Unbiased assessment of global amyloid load as determined by Voxel-wise receiver operating characteristic analysisTherriault | Pascoal | Mathotaarachchi | Alves | Collij | Kang | Savard | Benedet | Knight | Ng | Shin | Chamoun | Massarweh | Soucy | Gauthier | Rosa-NetoTherriault, Joseph
1Differing patterns of [18F]AV-1451 uptake in primary progressive apraxia of speech and agrammatic primary progressive aphasiaUtianski | Schwarz | Duffy | Clark | Machulda | Senjem | Jack | Lowe | Whitwell | JosephsUtianski, Rene
11Parametric imaging of [18F]florbetapir: a test-retest study in healthy subjects and patients with Alzheimer's diseaseVerfaillie | Golla | van der Weijden | Timmers | Schober | Schuit | Windhorst | Scheltens | van der Flier | Lammertsma | van Berckel | BoellaardVerfaillie, Sander C.J.
5Sleep efficiency moderates the relationship between beta-amyloid and memory retentionWilckens | Tudorascu | Snitz | Price | Aizenstein | Lopez | Erickson | Lopresti | Laymon | Minhas | Mathis | Buysse | Klunk | CohenWilckens, Kristine
42Parametric methods for [18F]flortaucipir PETWolters | Golla | Timmers | Ossenkoppele | van der Weijden | Scheltens | Schwarte | Mintun | Devous | Schuit | Windhorst | Lammertsma | Yaqub | van Berckel | BoellaardWolters, Emma E
43Improved quantification of [18F]flortaucipir uptake in the hippocampus after partial volume correctionWolters | Golla | Timmers | Ossenkoppele | van der Weijden | Scheltens | Schwarte | Mintun | Devous | Schuit | Windhorst | Barkhof | Yaqub | Lammertsma | Boellaard | van BerckelWolters, Emma E
44Amyloid deposition is associated with different patterns of hippocampal connectivity in men versus womenWu | Thurston | Tudorascu | Karim | Mathis | Lopresti | Kamboh | Cohen | Snitz | Klunk | AizensteinWu, Minjie
18Noise reduction algorithm for amyloid image preserving image resolution — quantitative evaluation using clinical imagesYamada | Kimura | Fuji | Watanabe | Nagaoka | Nemoto | Hanaoka | Kaida | Hosokawa | IshiiYamada, Takahiro
28Head-to-head comparison of 11C-PBR28 and 18F-GE180 for the quantification of TSPO in the human brainZanotti Fregonara | Pascual | Rizzo | Yu | Pal | Beers | Carter | Appel | Atassi | MasdeuZanotti Fregonara, Paolo
2PBR-28 binding is elevated in Alzheimer's disease but not in suspected non-AD pathophysiologyZou | Razlighi | Klein | Polly | Stern | KreislZou, James
POSTER SESSIONS: 2A - Thursday, January 18 - 10:15 - 11:00; 2B - Thursday, January 18, 4:50 - 5:35
Board #Poster TitleAuthorsPresenter
50Quantitative thresholding of [18F]Florbetapir brain uptake using Thal phases of Abeta deposition relate to clinical stages of diseaseSeneca | Burger | FloreaSeneca, Nicholas
51Potential use of 18F-THK5351 PET to identify gliosis: Wallerian degeneration of the pyramidal tract after a cerebral infarctionIshibashi | Kameyama | Tago | Toyohara | IshiiIshibashi, Kenji
52Preclinical evaluation of 18F-THK5351 off-target binding to melanin-containing cellsTago | Toyohara | Harada | Furumoto | Okamura | Kudo | Takahashi-Fujigasaki | Murayama | IshiiTago, Tetsuro
53To tau or to MAO-B? Most of the 18F-THK5351 signal is blocked by selegilineVillemagne | Doré | Okamura | Baxendale | Harada | Mulligan | Furumoto | Salvado | Yanai | Masters | RoweVillemagne, Victor L
54[18F]MK-6240 autoradiography in AD, PSP, and CBDBetthauser | Runde | Johnson | Salamat | Roy | ChristianBetthauser, Tobey
55Imaging-autopsy correlation of 18F-THK5351 in typical and atypical cases of progressive supranuclear palsyHarada | Ishiki | Kai | Furukawa | Furumoto | Tashiro | Kitamoto | Kudo | Yanai | Arai | OkamuraHarada, Ryuichi
56Relationship of basal ganglia mineralization to "off-target" AV-1451 binding in Down syndromeZammit | Laymon | Minhas | Tudorescu | Lopresti | Mathis | Sabbagh | Zaman | Klunk | Handen | Christian | CohenZammit, Matthew
57Structure and distribution of amyloid betaJoseph | Sparling | StysJoseph, Jeffrey T
58Confocal analysis of fluorescent signal derived from CN-Flutemetamol-labeled diffuse and neuritic plaques in Alzheimer’s diseaseIkonomovic | Buckley | Abrahamson | Mathis | Klunk | FarrarIkonomovic, Milos
59Comparison of Down syndrome PiB PET templates for MRI-less PET quantificationMinhas | Laymon | Tudorascu | Lao | Campbell | Yu | Lopresti | Mathis | Klunk | Handen | Christian | CohenMinhas, Davneet
60Trajectories of fiber tract impairment in autosomal dominant Alzheimer's diseaseAraque Caballero | Benzinger | Suarez-Calvet | Levin | Morris | Bateman | Haass | EwersEwers, Michael
61The BDNF Val66Met SNP is related to hippocampal connectivity and cognitive decline in autosomal dominant Alzheimer’s diseaseFranzmeier | Ren | Levin | Bateman | Morri | Benzinger | EwersFranzmeier, Nicolai
62Tau accumulation and memory decline are more closely related to striatal than cortical amyloidosis in individuals with early-onset autosomal dominant Alzheimer's diseaseHanseeuw | Lopera | Sperling | Norton | Guzman-Velez | Baena | Schultz | Gatchel | Jin | Chen | Reiman | Johnson | QuirozHanseeuw, Bernard
63Tau pathology in Down syndromeLemoine | Bharani | Hamlett | Perez | Mufson | Poon | Simic | Nordberg | GranholmLemoine, Laetitia
64Singular Value Decomposition (SVD) identification of PiB and FDG topographies in Dominantly Inherited Alzheimer's Network (DIAN)Loe | Brier | McCarthy | Stern | Kuffner | Morris | Bateman | Benzinger | AncesLoe, Maren
65[18F]AV-1451 tau PET imaging in MAPT 10+16 mutation carriersClarke | Jiao | Dick | Convery | Koriath | Woollacott | Weston | Gunn | Rabiner | Rossor | Warren | Fox | Ourselin | Bocchetta | RohrerClarke, Mica
66Longitudinal change of functional connectivity in the DIAN cohort: functional connectivity as a longitudinal biomarker in Autosomal Dominant ADSchultz | Sperling | Buckley | Johnson | Benzinger | Ances | Morris | Buckles | Xiong | McDade | Cairns | Marcus | Fulbright | Jack | Ringman | Farlow | Kinnunen | Fox | Masters | Schofield | Salloway | Levin | Bateman | ChhatwalSchultz, Aaron
67An UNC5C locus is associated with susceptibility to cognitive decline and hippocampal neurodegeneration in clinically normal older adultsYang | Chhatwal | Papp | Rabin | Hanseeuw | Mormino | Buckley | Schultz | Properzi | Hedden | Marshall | Rentz | Johnson | De Jager | SperlingYang, Hyun-Sik
68CYP2C19 effects in brain amyloid load and hippocampus' functional integrityLessa Benedet | Iturria-Medina | Savard | Kang | Mathotaarachchi | A. Pascoal | Therriault | Shin | Gauthier | C. Evans | Labbe | Rosa-NetoLessa Benedet, Andrea
69Relationships between [11C]PiB positivity and an imaging marker of cerebrovascular pathology positivityBerman | Allison | Christian | Betthauser | Oh | Asthana | Carlsson | Bendlin | JohnsonBerman, Sara
70[18F]Fluorotaucipir binding in patients with cerebral amyloid angiopathy without hemorrhage and mild cognitive symptomsJin | Benson | Schultz | Becker | Charidimou | Fotiadis | Katz | Luner | Moody | Sanchez | Sperling | Xiong | Viswanathan | JohnsonJin, David
71Amyloid imaging in hereditary cerebral amyloid angiopathy: detection and progression of pure vascular amyloid caused by APP E693QSchultz | Kloet | Sohrabi | Chatterjee | Gardnener | Taddei | Benzinger | Fagan | Sperling | Johnson | Bateman | Gurol | van Buchem | Martins | Chhatwal | GreenbergChhatwal, Jasmeer
72Midlife insulin resistance and APOE genotype are associated with late-life brain amyloid accumulationRinne | Ekblad | Johansson | Helin | Viitanen | Laine | Puukka | JulaRinne, Juha
73Flortaucipir PET imaging and neuropsychological performances dissociate dorsal and ventral stream dysfunction in Posterior Cortical AtrophyPutcha | Collins | Wong | Dickerson | McGinnisPutcha, Deepti
74Amyloid network topology characterizes the progression of Alzheimer’s disease during the pre-dementia stagesPereira | Strandberg | Palmqvist | Volpe | van Westen | Westman | HanssonPereira, Joana
75In pre-clinical AD, subjective cognitive decline is associated with brain hyperactivation in conflict monitoring/control regionsMizuno | Karim | Rangarajan | Klunk | Aizenstein | SnitzMizuno, Akiko
76How useful is amyloid PET in clinical diagnosis? A systematic review and meta-analysisFantoni | Chalkidou | O'Brien | Farrar | HammersFarrar, Gill
77[18F]AV-1451 binds to an unidentified white matter target in semantic dementiaWhitwell | Martin | Schwarz | Duffy | Clark | Machulda | Botha | Graff-Radford | Jones | Utianski | Knopman | Petersen | Lowe | Jack | JosephsWhitwell, Jennifer
78Quantifying stages of subtle memory impairment in clinically normal older adultsPapp | Mormino | Grober | Sperling | Johnson | RentzPapp, Kate
79The relationship between amyloid deposition and both global and hippocampal atrophyAllison | Berman | Clark | Christian | Betthauser | Oh | Asthana | Bendlin | JohnsonAllison, Samantha
80AV1451-PET measurements show substantial overlap across diagnostic groups and amyloid statusLandau | Korman | JagustLandau, Susan
81Shrinking cortex and tau burden in the aphasic variant of Alzheimer's diseaseMartersteck | Sridhar | Rainford | Mesulam | RogalskiMartersteck, Adam
82Cross-sectional associations between tau pathology burden measured by [18F]GTP1 PET imaging and cognition in AD adjusting for amyloid PET and cortical atrophyWard | Manser | Teng | Sanabria-Bohorquez | Ray | Baker | Kerchner | WeimerWard, Michael
83Cognition and [18F]-Florbetaben PET imaging of amyloid in Parkinson’s diseaseStark | Melzer | Keenan | Myall | Kaur | Livingston | Horne | Marsh | Grenfell | Young | MacAskill | Dalrymple-Alford | AndersonStark, Megan
84Increased central arterial stiffening relates to CSF markers of tau aggregation and neurodegeneration in the oldest-oldCambronero | Liu | Moore | Babicz | Hohman | Gifford | Bell | Acosta | Terry | Nair | Wang | Carr | Blennow | Zetterberg | JeffersonCambronero, Francis E.
85Alterations in memory self-appraisal are associated with elevated tau deposition in normal older adultsd'Oleire Uquillas | Schultz | Jacobs | Hanseeuw | Buckley | Pascual-Leone | Sperling | Johnson | Vanninid'Oleire Uquillas, Federico
86Segregation of tau deposits across clinical stages provides the basis for pathophysiological staging in ADMathotaarachchi | A. Pascoal | L. Benedet | Shin | Kang | Struyfs | Therriault | Chamoun | Ng | Savard | Knight | Gauthier | Rosa-NetoMathotaarachchi, Sulantha
87Increasing A? is associated with nonlinear change in BOLD modulation to difficulty in cognitively normal middle-aged and older adults: further evidence from an n-back taskFoster | M. Kennedy | RodrigueFoster, Chris
88Co-existence of deleterious and neuroprotective interaction between amyloid and neuroinflammation in late stage Alzheimer's diseaseKnight | Kang | Parent | Pascoal | Mathotaarachchi | Therriault | Benedet | Camoun | Aliaga | Zimmer | Shin | Aliaga | Kostikov | Soucy | Gauthier | Cuello | Rosa-NetoKnight, Ashley
89Amyloid and tau deposition determine cognitive impairment through epigenetic changes in individuals across the AD spectrumPascoal | Shin | Kang | Ng | Benedet | Mathotaarachchi | Therriault | Chamoun | Massarweh | Knight | Soucy | Gauthier | Rosa-NetoPascoal, Tharick
9018F-AV-1451 uptake on tau PET differs between dementia with Lewy bodies and posterior cortical atrophyNedelska | Josephs | Graff-radford | Przybelski | Lesnick | Boeve | Lowe | Drubach | Knopman | Petersen | Jack, Jr. | Whitwell | KantarciNedelska, Zuzana
91Finding ground zero: identifying the medial temporal origin of tau deposition during lifeSanchez | Augustinack | Becker | Jacobs | Jin | Katz | Luner | Moody | Rentz | Sperling | Price | JohnsonSanchez, Justin
92Age-related change of THK-5351 PET in amyloid-negative and non-demented elderly subjectsKato | Iwata | Kizawa | Fukaya | Kuratsubo | Kimiura | Okamura | Yanai | Ito | Nakamura | Study GroupKato, Takashi
93Human testing of non-selective alpha-synuclein PET tracersBorroni | Honer | Gobbi | Mathis | Klunk | Kotzbauer | Tu | Mach | Mitchell | Marek | EberlingBorroni, Edilio
POSTER SESSIONS: 3A - Friday, January 19, 10:15 - 11:00; 3B - Friday, January 19, 4:15 - 5:00
Board #Poster TitleAuthorsPresenter
100Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than Aβ PET pathologyMcCullough | Gordon | Mishra | Blazey | Su | Christensen | Dincer | Jackson | Hornbeck | Morris | Ances | BenzingerMcCullough, Austin
101[18F]Florbetapir binding potential in relation to cognition in subjective cognitive declineTimmers | Verfaillie | Wesselman | Slot | Prins | van der Weijden | Yaqub | Lammertsma | Boellaard | Ossenkoppele | van der Flier | van BerckelTimmers, Tessa
102Application of the PredictND decision support system to cross-sectional imaging and psychometric data from an aMCI to probable AD three year outcomes clinical studyBuckley | Moreland | Urhemaa | van Gils | Wolber | lotjonenBuckley, Chris
103Tau pathology detected by [18F]GTP1 negatively correlates with cortical volume in Alzheimer's diseaseRay | Baker | Manser | Ward | Teng | Weimer | Sanabria BohórquezSanabria Bohórquez, Sandra
104Assessing the impact of beta-amyloid deposition in progressive supranuclear palsyBoland | Ahlskog, PhD, MD | Tosakulwong, BS | Senjem, MS | Spychalla, BS | Petersen, MD | Jack Jr, MD | Lowe, MD | Josephs, MD, MST, MSc | Whitwell, PhDBoland, Sarah
105Flortaucipir imaging in primary progressive aphasia predicts variability in language impairmentCollins | Quimby | Makaretz | Sweeney | Wong | McGinnis | DickersonCollins, Jessica
106[18F]flutemetamol amyloid binding potential in relation to memory in cognitively normal subjects aged 80 years and olderLegdeur | Buslenko | Konijnenberg | ten Kate | Badissi | Tomassen | den Braber | Yaqub | Boomsma | Lammertsma | Maier | Scheltens | van Berckel | VisserLegdeur, Nienke
107Amyloid-? load is related to worries in individuals with subjective cognitive declineVerfaillie | Timmers | Slot | van der Weijden | Wesselman | Prins | Sikkes | Lammertsma | Scheltens | Ossenkoppele | van Berckel | van der FlierVerfaillie, Sander
108[18F]Flutemetamol imaging in the ALFA project: Cognitively healthy subjects enriched for Alzheimer's disease genetic risk factorsSalvadó | Brugulat | Falcon | Pavia | Lomeña | Molinuevo | GispertSalvadó, Gemma
109Is there a local neurotoxic effect of regional amyloid deposits? A network-domain specific study of florbetapir-PET – cognition associationsGrothe | Sorg | TeipelGrothe, Michel
110A similar prevalence and magnitude of amyloid positivity between cognitively normal elderly Japanese and AmericansYu | Lopresti | Ihara | Cui | Aizenstein | Dodge | Minhas | Lopez | Klunk | Mathis | Kuller | Miyamoto | SekikawaLopresti, Brian
111Effects of amyloid deposition and hippocampal activation on subjective memory complaintsChen | Jingting | Farrell | ParkChen, Xi
112Thresholds for amyloid positivity among normal, MCI and mild dementia subjects using [F-18] FlorbetabenDuara | Loewenstein | Lizzaraga | Adjouadi | Barker | Greig-Custo | Penate | Hanson | Marsiske | Vaillancourt | DeKosky | GoldeDuara, Ranjan
113Twelve-month glucose metabolism declines in an empirically pre-defined statistical region-of-interest in amyloid-positive persons with Alzheimer's dementia and Mild Cognitive Impairment: updated ADNI findingsChen | Lee | Kuang | Luo | Devadas | Thiyyagura | Chen | Bauer | Weiner | Jagust | Van Dyck | ReimanChen, Kewei
114Flortaucipir PET measurements and relationships with cognitive impairmentProtas | Ghisays | Luo | DeMarco | Thiyyagura | Devadas | Bauer | Landau | Weiner | Jagust | Reiman | ChenProtas, Hillary
115[18F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentationAli | Whitwell | Martin | Senjen | Knopman | Jack Jr. | Lowe | Petersen | Boeve | JosephsAli, Farwa
116Tau positron emission tomography is not elevated in HIV infected individualsAnces | Beaumont | Cooley | Strain | Morris | BenzingerAnces, Beau
117Left frontal hub connectivity delays cognitive decline in autosomal dominant and sporadic Alzheimer's diseaseFranzmeier | Duezel | Jessen | Benzinger | Levin | Fagan | Morris | Bateman | EwersFranzmeier, Nicolai
118Sex and e4 genotype influence the longitudinal association between amyloid and tau pathology in clinically normal older adultsHanseeuw | Buckley | Mormino | Jacobs | Chhatwal | Gomez | Johnson | SperlingHanseeuw, Bernard
119The DCTclockTM test captures subtle cognitive changes and biomarker evidence of preclinical Alzheimer's diseaseRentz | Papp | Orlovsky | Souillard-Mandar | Penney | Davis | JohnsonRentz, Dorene
120Evidence for neuroinflammation in semantic dementiaPascual | Zanotti-Fregonara | Pal | Rockers | Funk | Yu | Roman | Schultz | MasdeuPascual, Belen
121Cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide 42 may improve the prediction of amyloid PET positivity: data from the Czech Brain Ageing StudyCerman | Laczo | Vyhnalek | Sheradova | Ferda | Belohlavek | HortCerman, Jiri
122Relationships between self-reported sleep, tau, and A? in healthy older adultsWiner | Maass | Harrison | Mellinger | Baker | Walker | JagustWiner, Joseph
12318F-AV1451 tau PET in patients at risk for chronic traumatic encephalopathyLesman-Segev | La Joie | Tsai | Bourakova | Visani | Ayakta | P O'Neil | Maass | Baker | Perry | Kramer | Miller | Jagust | RabinoviciLesman-Segev, Orit
124Longitudinal [18F]THK5317 and [18F]FDG PET in relation to novel CSF tau fragments in Alzheimer’s disease and related primary tauopathiesLeuzy | Chiotis | Cicognola | Saint-Aubert | Zetterberg | Blennow | Höglund | NordbergLeuzy, Antoine
125Tau pathology networks associated with functional connectivity networks and disease progression in Alzheimer’s diseaseHönig | Bischof | Seemiller | Hammes | Fink | van Eimeren | DrzezgaHönig, Merle
126Characterizing regional ?-amyloid burden by magnetic susceptibilityUnschuld | van Bergen | Li | Quevenco | Gietl | Treyer | Meyer | Buck | Kaufmann | Nitsch | van Zijl | HockUnschuld, Paul
127Tau aggregates imaged with 18F-Flortaucipir PET contribute to core clinical features of the Lewy body dementiasKatz | Ye | Shirvan | Schultz | Makaretz | Dickerson | Sperling | Growdon | Johnson | GompertsKatz, Samantha
128Nucleus basalis of Meynert volume predicts early tau pathology and memory performance when amyloid levels are elevated in cognitively normal older individualsJacobs | Hanseeuw | Schultz | Papp | Rentz | Sperling | JohnsonJacobs, Heidi
129Increased GM regions in association with SUVR are candidate to predict convergence to Preclinical ADMonté-Rubio | Rodriguez-Gomez | Sanabria | Alegret | Perez-Cordon | Lomeña | Pavia | Gismondi | Bullich | Vivas-Larruy | Gomez-Chiari | Ruiz-Laza | Tárraga | BoadaMonté-Rubio, Gemma
130Distinct [18F]-THK5351 binding patterns in primary progressive aphasia variantsSchaeverbeke | Gabel | Bruffaerts | Meersmans | Van Bouwel | Dries | Peeters | Van Laere | Dupont | VandenbergheSchaeverbeke, Jolien
131Multiple brain markers contribute to age-related changes in cognitionHedden | Nierle | Perea | Rabin | Buckley | Schultz | Johnson | SperlingHedden, Trey
132The BioFINDER-2 study: a longitudinal investigation on the role of Tau and amyloid on cognitive function using 18F-RO6958948 and 18-Flutemetamol PET tracersHansson | Mattsson | Smith | Schöll | Klein | Farrar | Borroni | Coloma | Palmqvist | StomrudHansson, Oskar
133PiB PET as a biomarker for white matter integrity in aging and dementiaSu | Wang | Flores | Wang | Beau | Morris | BenzingerSu, Yi
134Effects of tau and amyloid deposition on domain-specific memory function in old ageMaass | Berron | Harrison | Baker | Mellinger | Swinnerton | Bell | Duezel | JagustMaass, Anne
135Effects of amyloid, tau, and hippocampal volume on normal and fast gait speeds in cognitively normal older adults: results from the Harvard Aging Brain studyKirn | Buckley | Hanseeuw | Klein | Properzi | Sperling | JohnsonKirn, Dylan
136[18F]-THK5351 binding patterns are associated with language deficits in primary progressive aphasiaGabel | Schaeverbeke | Meersmans | Bruffaerts | Van Bouwel | Dries | Peeters | Van Laere | Dupont | VandenbergheGabel, Silvy
137Personality traits and neuropsychiatric factors are related to increased amyloid deposition in cognitively normal older adultsPichet Binette | Vachon-Presseau | Gonneaud | Marchant | Bellec | Breitner | Villeneuve | Research GroupPichet Binette, Alexa
138Tau deposition in relation to verbal and phonemic fluency in the Framingham Heart StudyLuner | Jacobs | Papp | Becker | Beiser | Daniluk | Himali | Jin | Katz | Killiany | Moody | Pase | Peets | Raman | Sanchez | Satizabal | Schafer | Seshadri | JohnsonLuner, Evelyn
139Long-term clinical stability in amyloid-positive subjects is predicted by negative FDG-PET scanIaccarino | Sala | PeraniIaccarino, Leonardo
140Associations between tau, A? and cortical thickness with cognition in Alzheimer’s diseaseOssenkoppele | Smith | Ohlsson | Mattsson | Strandberg | Palmqvist | HanssonOssenkoppele, Rik
141Longitudinal relationships between brain amyloid deposition and glucose metabolism across the Alzheimer’s disease spectrumBejanin | Arenaza-Urquijo | De Flores | Tomadesso | ChételatBejanin, Alexandre

2018 Poster Sessions